|
|
 Previous Article | Table of Contents | Next Article 
Blood, 1 April 2001, Vol. 97, No. 7, pp. 1951-1959
GENE THERAPY
Induction of cytotoxic T lymphocyte and antibody responses to
enhanced green fluorescent protein following transplantation of
transduced CD34+ hematopoietic cells
Michael Rosenzweig,
Michelle Connole,
Rhona Glickman,
Soon-Pak Shinji Yue,
Bradley Noren,
MaryAnn DeMaria, and
R. Paul Johnson
From the New England Regional Primate Research Center,
Harvard Medical School, Southborough, MA; and Partners AIDS Research
Center and Infectious Disease Unit, Massachusetts General Hospital,
Harvard Medical School, Charlestown, MA.
Genetic modification of hematopoietic stem cells often results in
the expression of foreign proteins in pluripotent progenitor cells and
their progeny. However, the potential for products of foreign genes
introduced into hematopoietic stem cells to induce host immune
responses is not well understood. Gene marking and induction of immune
responses to enhanced green fluorescent protein (eGFP) were examined in
rhesus macaques that underwent nonmyeloablative irradiation followed by
infusions of CD34+ bone marrow cells transduced with a
retroviral vector expressing eGFP. CD34+ cells were
obtained from untreated animals or from animals treated with
recombinant human granulocyte colony-stimulating factor (G-CSF) alone
or G-CSF and recombinant human stem cell factor. Levels of
eGFP-expressing cells detected by flow cytometry peaked at 0.1% to
0.5% of all leukocytes 1 to 4 weeks after transplantation. Proviral
DNA was detected in 0% to 17% of bone marrow-derived colony-forming
units at periods of 5 to 18 weeks after transplantation. However, 5 of
6 animals studied demonstrated a vigorous eGFP-specific cytotoxic T
lymphocyte (CTL) response that was associated with a loss of
genetically modified cells in peripheral blood, as demonstrated by both
flow cytometry and polymerase chain reaction. The eGFP-specific CTL
responses were MHC-restricted, mediated by CD8+
lymphocytes, and directed against multiple epitopes. eGFP-specific CTLs
were able to efficiently lyse autologous CD34+ cells
expressing eGFP. Antibody responses to eGFP were detected in 3 of 6 animals. These data document the potential for foreign proteins
expressed in CD34+ hematopoietic cells and their progeny to
induce antibody and CTL responses in the setting of a clinically
applicable transplantation protocol.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
E. J. Akins and P. Dubey
Noninvasive Imaging of Cell-Mediated Therapy for Treatment of Cancer
J. Nucl. Med.,
June 1, 2008;
49(Suppl_2):
180S - 195S.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Annoni, M. Battaglia, A. Follenzi, A. Lombardo, L. Sergi-Sergi, L. Naldini, and M.-G. Roncarolo
The immune response to lentiviral-delivered transgene is modulated in vivo by transgene-expressing antigen-presenting cells but not by CD4+CD25+ regulatory T cells
Blood,
September 15, 2007;
110(6):
1788 - 1796.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Traversari, S. Marktel, Z. Magnani, P. Mangia, V. Russo, F. Ciceri, C. Bonini, and C. Bordignon
The potential immunogenicity of the TK suicide gene does not prevent full clinical benefit associated with the use of TK-transduced donor lymphocytes in HSCT for hematologic malignancies
Blood,
June 1, 2007;
109(11):
4708 - 4715.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y.-W. Pan, J. M. Scarlett, T. T. Luoh, and P. Kurre
Prolonged Adherence of Human Immunodeficiency Virus-Derived Vector Particles to Hematopoietic Target Cells Leads to Secondary Transduction In Vitro and In Vivo
J. Virol.,
January 15, 2007;
81(2):
639 - 649.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H.-P. Kiem, J. Allen, G. Trobridge, E. Olson, K. Keyser, L. Peterson, and D. W. Russell
Foamy virus-mediated gene transfer to canine repopulating cells
Blood,
January 1, 2007;
109(1):
65 - 70.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Berger, M. E. Flowers, E. H. Warren, and S. R. Riddell
Analysis of transgene-specific immune responses that limit the in vivo persistence of adoptively transferred HSV-TK-modified donor T cells after allogeneic hematopoietic cell transplantation
Blood,
March 15, 2006;
107(6):
2294 - 2302.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. J. Cohen, Z. Zheng, R. Bray, Y. Zhao, L. A. Sherman, S. A. Rosenberg, and R. A. Morgan
Recognition of Fresh Human Tumor by Human Peripheral Blood Lymphocytes Transduced with a Bicistronic Retroviral Vector Encoding a Murine Anti-p53 TCR
J. Immunol.,
November 1, 2005;
175(9):
5799 - 5808.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V Tepavcevic and W.F Blakemore
Glial grafting for demyelinating disease
Phil Trans R Soc B,
September 29, 2005;
360(1461):
1775 - 1795.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R.-J. Swijnenburg, M. Tanaka, H. Vogel, J. Baker, T. Kofidis, F. Gunawan, D. R. Lebl, A. D. Caffarelli, J. L. de Bruin, E. V. Fedoseyeva, et al.
Embryonic Stem Cell Immunogenicity Increases Upon Differentiation After Transplantation Into Ischemic Myocardium
Circulation,
August 30, 2005;
112(9_suppl):
I-166 - I-172.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Abedi, D. A. Greer, B. M. Foster, G. A. Colvin, J. A. Harpel, D. A. Demers, J. Pimentel, M. S. Dooner, and P. J. Quesenberry
Critical variables in the conversion of marrow cells to skeletal muscle
Blood,
August 15, 2005;
106(4):
1488 - 1494.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Yoshioka, N. Ageyama, H. Shibata, T. Yasu, Y. Misawa, K. Takeuchi, K. Matsui, K. Yamamoto, K. Terao, K. Shimada, et al.
Repair of Infarcted Myocardium Mediated by Transplanted Bone Marrow-Derived CD34+ Stem Cells in a Nonhuman Primate Model
Stem Cells,
March 1, 2005;
23(3):
355 - 364.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. E. Donahue, I. S. Y. Chen, J. C. Morris, and H.-P. Kiem
Transgene-specific tolerance versus immune response
Blood,
September 1, 2004;
104(5):
1578 - 1579.
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. A. Horn, K. A. Keyser, L. J. Peterson, T. Neff, B. M. Thomasson, J. Thompson, and H.-P. Kiem
Efficient lentiviral gene transfer to canine repopulating cells using an overnight transduction protocol
Blood,
May 15, 2004;
103(10):
3710 - 3716.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Berger, C. A. Blau, M.-L. Huang, J. D. Iuliucci, D. C. Dalgarno, J. Gaschet, S. Heimfeld, T. Clackson, and S. R. Riddell
Pharmacologically regulated Fas-mediated death of adoptively transferred T cells in a nonhuman primate model
Blood,
February 15, 2004;
103(4):
1261 - 1269.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. C. Morris, M. Conerly, B. Thomasson, J. Storek, S. R. Riddell, and H.-P. Kiem
Induction of cytotoxic T-lymphocyte responses to enhanced green and yellow fluorescent proteins after myeloablative conditioning
Blood,
January 15, 2004;
103(2):
492 - 499.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Andersson, B. M. W. Illigens, K. W. Johnson, D. Calderhead, C. LeGuern, G. Benichou, M. E. White-Scharf, and J. D. Down
Nonmyeloablative conditioning is sufficient to allow engraftment of EGFP-expressing bone marrow and subsequent acceptance of EGFP-transgenic skin grafts in mice
Blood,
June 1, 2003;
101(11):
4305 - 4312.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Baum, J. Dullmann, Z. Li, B. Fehse, J. Meyer, D. A. Williams, and C. von Kalle
Side effects of retroviral gene transfer into hematopoietic stem cells
Blood,
March 15, 2003;
101(6):
2099 - 2113.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. D. Down and M. E. White-Scharf
Reprogramming Immune Responses: Enabling Cellular Therapies and Regenerative Medicine
Stem Cells,
January 1, 2003;
21(1):
21 - 32.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Kondo, M. S. Topp, H.-P. Kiem, Y. Obata, Y. Morishima, K. Kuzushima, M. Tanimoto, M. Harada, T. Takahashi, and Y. Akatsuka
Efficient Generation of Antigen-Specific Cytotoxic T Cells Using Retrovirally Transduced CD40-Activated B Cells
J. Immunol.,
August 15, 2002;
169(4):
2164 - 2171.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. D. Brown and D. Lillicrap
Dangerous liaisons: the role of "danger" signals in the immune response to gene therapy
Blood,
July 30, 2002;
100(4):
1133 - 1140.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Srinivasakumar, M. Zaboikin, T. Zaboikina, and F. Schuening
Evaluation of Tat-Encoding Bicistronic Human Immunodeficiency Virus Type 1 Gene Transfer Vectors in Primary Canine Bone Marrow Mononuclear Cells
J. Virol.,
June 14, 2002;
76(14):
7334 - 7342.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
